$GATO
Gatos Silver, Inc.

2022 Q1 Form 10-Q Financial Statement

#000110465923038835 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.780M $3.600M
YoY Change 88.33% 328.57%
% of Gross Profit
Research & Development $110.0K $220.0K
YoY Change -50.0% 29.41%
% of Gross Profit
Depreciation & Amortization $40.00K $10.00K
YoY Change 300.0% 0.0%
% of Gross Profit
Operating Expenses $6.930M $3.830M
YoY Change 80.94% 275.49%
Operating Profit
YoY Change
Interest Expense $6.730M $2.700M
YoY Change 149.26% -120.07%
% of Operating Profit
Other Income/Expense, Net $1.146M -$490.0K
YoY Change -333.88% -68.99%
Pretax Income $1.050M -$1.620M
YoY Change -164.81% -89.9%
Income Tax
% Of Pretax Income
Net Earnings $18.83M -$1.620M
YoY Change -1262.28% -90.91%
Net Earnings / Revenue
Basic Earnings Per Share $0.27 -$0.03
Diluted Earnings Per Share $0.27 -$27.24K
COMMON SHARES
Basic Shares Outstanding 69.16M 59.32M
Diluted Shares Outstanding 69.31M 59.32M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.300M $31.00M
YoY Change -82.9%
Cash & Equivalents $5.284M $31.00M
Short-Term Investments
Other Short-Term Assets $2.850M $3.300M
YoY Change -13.64%
Inventory
Prepaid Expenses $2.219M
Receivables
Other Receivables
Total Short-Term Assets $8.764M $39.60M
YoY Change -77.87%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $379.8M $226.1M
YoY Change 67.98%
Other Assets $28.00K $100.0K
YoY Change -72.0%
Total Long-Term Assets $379.8M $226.1M
YoY Change 68.0%
TOTAL ASSETS
Total Short-Term Assets $8.764M $39.60M
Total Long-Term Assets $379.8M $226.1M
Total Assets $388.6M $265.7M
YoY Change 46.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $330.0K $300.0K
YoY Change 10.0%
Accrued Expenses $1.129M $3.000M
YoY Change -62.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.600M $3.500M
YoY Change -25.71%
LONG-TERM LIABILITIES
Long-Term Debt $12.70M $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $12.70M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.600M $3.500M
Total Long-Term Liabilities $12.70M $0.00
Total Liabilities $15.20M $3.500M
YoY Change 334.29%
SHAREHOLDERS EQUITY
Retained Earnings -$172.0M
YoY Change
Common Stock $117.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $373.4M $262.1M
YoY Change
Total Liabilities & Shareholders Equity $388.6M $265.7M
YoY Change 46.26%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $18.83M -$1.620M
YoY Change -1262.28% -90.91%
Depreciation, Depletion And Amortization $40.00K $10.00K
YoY Change 300.0% 0.0%
Cash From Operating Activities -$1.332M -$6.590M
YoY Change -79.79% 39.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$113.8M
YoY Change -100.0% 4311.63%
Cash From Investing Activities $0.00 -$113.8M
YoY Change -100.0% 4311.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.300M
YoY Change -100.0% -665.22%
NET CHANGE
Cash From Operating Activities -1.332M -6.590M
Cash From Investing Activities 0.000 -113.8M
Cash From Financing Activities 0.000 1.300M
Net Change In Cash -1.332M -119.1M
YoY Change -98.88% 1481.81%
FREE CASH FLOW
Cash From Operating Activities -$1.332M -$6.590M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001517006
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Gatos Silver, Inc.
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-39649
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver, British Columbia
CY2022Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
CY2022Q1 dei City Area Code
CityAreaCode
604
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
424-0984
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
GATO
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5284000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6616000
CY2022Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
630000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1592000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2850000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
8764000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11766000
CY2022Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
379818000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
355310000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2022Q1 us-gaap Assets
Assets
388610000
CY2021Q4 us-gaap Assets
Assets
367111000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2557000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12657000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12620000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
117000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
545311000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
543829000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-172032000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-190861000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
373396000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
388610000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367111000
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
110000
CY2021Q1 us-gaap Exploration Expense
ExplorationExpense
224000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6777000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4853000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
6931000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
5084000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24614000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2701000
CY2021Q1 gato Arrangements Fees
ArrangementsFees
506000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1146000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1269000
CY2022Q1 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
25760000
CY2021Q1 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
3464000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
18829000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59318320
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59318320
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
353085000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1482000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
18829000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
373396000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1078000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1559000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-262000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
262141000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
18829000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1620000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1588000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1139000
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
64000
CY2021Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
22000
CY2022Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
24614000
CY2021Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
2701000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-962000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
3508000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1087000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-507000
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-708000
CY2021Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-579000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1332000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6589000
CY2021Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
113823000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113823000
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
262000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1559000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1297000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1332000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-119115000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5284000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31031000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
102000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2976000
CY2022Q1 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2021Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2850000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q1 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
624000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
575000
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2219000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
330000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
196000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1129000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
623000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1098000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
587000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2557000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1588000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1139000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
18829000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1620000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
59318320
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
146796
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
59318320
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q3 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
442000
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
9000000
CY2022Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
103000
CY2022Q1 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.032
CY2022Q1 gato Line Of Credit Facility Decrease In Maximum Borrowing Capacity
LineOfCreditFacilityDecreaseInMaximumBorrowingCapacity
50000000
CY2022Q1 us-gaap Exploration Expense
ExplorationExpense
110000
CY2021Q1 us-gaap Exploration Expense
ExplorationExpense
224000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6777000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4853000
CY2022Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
44000
CY2021Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
7000
CY2021Q1 gato Arrangements Fees
ArrangementsFees
506000
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
24614000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2701000
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1146000
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
1269000
CY2022Q1 us-gaap Assets
Assets
388610000
CY2021Q1 us-gaap Assets
Assets
265680000

Files In Submission

Name View Source Status
0001104659-23-038835-index-headers.html Edgar Link pending
0001104659-23-038835-index.html Edgar Link pending
0001104659-23-038835.txt Edgar Link pending
0001104659-23-038835-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20220331.xsd Edgar Link pending
gato-20220331x10q.htm Edgar Link pending
gato-20220331x10q003.jpg Edgar Link pending
gato-20220331xex31d1.htm Edgar Link pending
gato-20220331xex31d2.htm Edgar Link pending
gato-20220331xex32d1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
gato-20220331_def.xml Edgar Link unprocessable
gato-20220331_lab.xml Edgar Link unprocessable
gato-20220331_pre.xml Edgar Link unprocessable
gato-20220331_cal.xml Edgar Link unprocessable
gato-20220331x10q_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable